World Viral Hepatitis Day in Burkina Faso, 2020: awareness, prevention and hepatitis B vaccine to achieve the WHO eradication goal by 2030

Hepatitis B vaccine coverage in Ouagadougou, Burkina Faso

Auteurs

  • Denise P. ILBOUDO 1.University of Fada N’Gourma, BP 54 Fada N'Gourma, Burkina Faso 2.Laboratory of Molecular Biology and Molecular Genetics (LABIOGENE) UFR/SVT, University Joseph KI- ZERBO, Burkina Faso ; BP 7021 Ouagadougou 03 3.Laboratory of Biochemistry and Applied Immunology, University Joseph KI-ZERBO, 03 BP 7021 Ouagadougou 03, Burkina Faso
  • Yéri Esther HIEN 3.Laboratory of Biochemistry and Applied Immunology, University Joseph KI-ZERBO, 03 BP 7021 Ouagadougou 03, Burkina Faso
  • Théodora M. ZOHONCON 2.Laboratory of Molecular Biology and Molecular Genetics (LABIOGENE) UFR/SVT, University Joseph KI- ZERBO, Burkina Faso ; BP 7021 Ouagadougou 03 ; 4.Université Saint Thomas d’Aquin, Faculté de Médecine, Ouagadougou, Burkina Faso ; 6.Hopital Saint Camille de Ouagadougou, SOS Heptatite Burkina
  • Lassina TRAORE 2.Laboratory of Molecular Biology and Molecular Genetics (LABIOGENE) UFR/SVT, University Joseph KI- ZERBO, Burkina Faso ; BP 7021 Ouagadougou 03 ; 5.Biomolecular Research Center Pietro Annigoni (CERBA), BP 364 Ouagadougou 01, Burkina Faso.
  • Wendkuuni Florencia DJIGMA 2.Laboratory of Molecular Biology and Molecular Genetics (LABIOGENE) UFR/SVT, University Joseph KI- ZERBO, Burkina Faso ; BP 7021 Ouagadougou 03 ; 4.Université Saint Thomas d’Aquin, Faculté de Médecine, Ouagadougou, Burkina Faso
  • Djéneba OUERMI 2.Laboratory of Molecular Biology and Molecular Genetics (LABIOGENE) UFR/SVT, University Joseph KI- ZERBO, Burkina Faso ; BP 7021 Ouagadougou 03 ; 4.Université Saint Thomas d’Aquin, Faculté de Médecine, Ouagadougou, Burkina Faso
  • Christelle M. NADEMBEGA 2.Laboratory of Molecular Biology and Molecular Genetics (LABIOGENE) UFR/SVT, University Joseph KI- ZERBO, Burkina Faso ; BP 7021 Ouagadougou 03 ; 4.Université Saint Thomas d’Aquin, Faculté de Médecine, Ouagadougou, Burkina Faso
  • Justine YARA6 6.Hopital Saint Camille de Ouagadougou, SOS Heptatite Burkina
  • Damintoti Simplice KAROU 7.Ecole Supérieure des Techniques Biologiques et Alimentaires (ESTBA-UL), Université de Lomé, Lomé, Togo
  • Yves TRAORE3 3.Laboratory of Biochemistry and Applied Immunology, University Joseph KI-ZERBO, 03 BP 7021 Ouagadougou 03, Burkina Faso
  • Jacques SIMPORE 2.Laboratory of Molecular Biology and Molecular Genetics (LABIOGENE) UFR/SVT, University Joseph KI- ZERBO, Burkina Faso ; BP 7021 Ouagadougou 03 ; 4.Université Saint Thomas d’Aquin, Faculté de Médecine, Ouagadougou, Burkina Faso ; 5.Biomolecular Research Center Pietro Annigoni (CERBA), BP 364 Ouagadougou 01, Burkina Faso ; 6.Hopital Saint Camille de Ouagadougou, SOS Heptatite Burkina

Mots-clés :

Hepatitis B, Awareness, Screening, Vaccination, Burkina Faso

Résumé

Burkina Faso is located in a region where hepatitis B is endemic with low vaccination coverage. The aim of this
study was to evaluate the vaccine coverage during Hepatitis B screening campaign organized by "SOS Hepatitis
Burkina"in Ouagadougou in July 2020.
A rapid HBsAg detection test (Abon Biopharma Guangzhou, Co., Ltd. China; sensitivity > 99.0%; specificity,
96.8%) was performed on 252 individuals who voluntarily agreed to participate in the study. This study was
approved by the Institutional Ethics Committee of the Centre de recherche Biomoleculaire Pietro Annigoni
(CERBA).
We included 252 participants aged 2 to 77 years (mean age 31.77±14.07 and 29.67±13.71 for males and females,
respectively). The prevalence of HBsAg was 18.25% (46/252) and was slightly high in the age groups 21-30 years
(23.71%) and 31-40 years (23.73%). Out of 252 participants, 25 HBV-negative participants were vaccinated, giving
a vaccination rate of 9.92%.
This study reports a high prevalence of HBV infection in Burkina Faso with low vaccination coverage. The study
suggests that more attention should be paid to HBV prevention in Burkina Faso

Téléchargements

Publiée

04/25/2024

Comment citer

ILBOUDO, D. P. ., HIEN, Y. E. ., ZOHONCON, T. M. ., TRAORE, L. ., DJIGMA, W. F., OUERMI, D. ., NADEMBEGA, C. M. ., YARA6 , J. ., KAROU, D. S., TRAORE3 , Y. ., & SIMPORE, J. . (2024). World Viral Hepatitis Day in Burkina Faso, 2020: awareness, prevention and hepatitis B vaccine to achieve the WHO eradication goal by 2030: Hepatitis B vaccine coverage in Ouagadougou, Burkina Faso. Sciences De La Santé, 44(2), 99–107. Consulté à l’adresse https://revuesciences-techniquesburkina.org/index.php/sciences_de_la_sante/article/view/1105

Articles les plus lus par le même auteur ou la même autrice

N.B. : ce module nécessite l'activation d'au moins un module de statistiques/rapport. Si vos modules de statistiques fournissent plus d'une mesure, veuillez également sélectionner une mesure principale sur la page des paramètres du site de l'administrateur ou sur la page des paramètres du responsable de la publication.